Intense Research for Effective Therapy

Throughout the world, more and more people are being diagnosed with diabetes. Projections are assuming that by 2030, considerably more than 400 million people will suffer from this metabolic disease. The causes of diabetes mellitus are mainly being overweight, following a sedentary lifestyle, and eating the wrong food. They lead from insulin resistance to the lack of insulin and a higher blood sugar level. 

Research done by WÖRWAG Pharma concentrates on the consequences of the disease, such as diabetic nerve damage. The aim is to encourage findings in the field of vitamins, minerals, and trace elements.

Company founder Dr. Fritz Wörwag has developed the active ingredient benfotiamine further and it became a milestone in the therapy of diabetic comorbidities. With its high bioavailability, it significantly contributes to protect against vitamin B1 deficiency.  

International clinical studies, meetings of experts, and symposia, plus close collaboration with research labs: We invest in science and clinical research so we can develop the best possible medications for our patients.